Moderna, Inc. - COMMON STOCK (MRNA)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
384,509,293
Total 13F shares
188,669,379
Share change
+20,597,422
Total reported value
$24,691,522,039
Put/Call ratio
116%
Price per share
$130.95
Number of holders
753
Value change
+$2,711,203,836
Number of buys
428
Number of sells
295

Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q1 2021

As of 31 Mar 2021, Moderna, Inc. - COMMON STOCK (MRNA) was held by 753 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 188,669,379 shares. The largest 10 holders included BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, Theleme Partners LLP, STATE STREET CORP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, BANQUE PICTET & CIE SA, and Bellevue Group AG. This page lists 761 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.